It is important to mention that by classifying NASH patients into low F1 and F2 fibrosis grades and high F3 and F4 fibrosis grades, C allele carriers in YAP1 rs11225163 lost its significant association with HCC development in NASH. This evidence concerns the gene YAP1 and metabolic dysfunction-associated steatohepatitis.